https://doctransparency.com/doctor/fl/miami-beach/simon-blanc-1255683652
Medicare Enrolled

Dr. Simon Blanc, M.D.

Internal Medicine · Miami Beach, FL
Speaking/Promotional
1500 BAY RD APT 1514, Miami Beach, FL 33139
3475531443
In practice since 2012 (13 years)
NPI: 1255683652 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Blanc from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Blanc? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Blanc

Dr. Simon Blanc is an internal medicine in Miami Beach, FL, with 13 years in practice.

Between the years covered by Open Payments, Dr. Blanc received a total of $117,207 from 67 pharmaceutical and/or device companies across 456 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Blanc is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice$ $117,207 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$117,207
Total received (2018-2024)
Avg $16,744/year across 7 years
Top 1% in FL for internal medicine
67
Companies
456
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$56,992 (48.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$42,936 (36.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,280 (14.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,691
2023
$4,369
2022
$22
2021
$60
2020
$46,138
2019
$60,665
2018
$4,263

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$38,559
Celgene Corporation
$27,439
AstraZeneca Pharmaceuticals LP
$16,012
Array BioPharma Inc.
$6,867
EMD Serono, Inc.
$6,503
Ipsen Biopharmaceuticals, Inc
$6,137
GENZYME CORPORATION
$4,345
Novartis Pharmaceuticals Corporation
$2,303
Puma Biotechnology, Inc.
$2,003
Heron Therapeutics, Inc.
$1,657
Merck Sharp & Dohme Corporation
$489
PFIZER INC.
$469
E.R. Squibb & Sons, L.L.C.
$422
Amgen Inc.
$415
Incyte Corporation
$379
Lilly USA, LLC
$257
Daiichi Sankyo Inc.
$231
Genentech USA, Inc.
$227
Janssen Scientific Affairs, LLC
$214
Coherus Biosciences Inc.
$211
Rigel Pharmaceuticals, Inc.
$176
Bayer HealthCare Pharmaceuticals Inc.
$170
ASD SPECIALTY HEALTHCARE, LLC
$136
TESARO, Inc.
$125
GlaxoSmithKline, LLC.
$124
Boehringer Ingelheim Pharmaceuticals, Inc.
$93
Pharmacyclics LLC, An AbbVie Company
$86
Tempus AI, Inc
$80
Seagen Inc.
$75
EISAI INC.
$63
Astellas Pharma US Inc
$62
Exelixis Inc.
$47
Takeda Pharmaceuticals U.S.A., Inc.
$44
Adaptive Biotechnologies Corporation
$44
MorphoSys, US Inc.
$44
Pharmacosmos Therapeutics Inc.
$41
TerSera Therapeutics LLC
$37
NanoString Technologies, Inc.
$33
Regeneron Healthcare Solutions, Inc.
$33
ADC Therapeutics America, Inc.
$30
Seattle Genetics, Inc.
$27
ARRAY BIOPHARMA INC
$26
ABBVIE INC.
$26
Spectrum Pharmaceuticals Inc.
$26
Agios Pharmaceuticals, Inc.
$26
SOBI, INC
$25
Lexicon Pharmaceuticals, Inc.
$25
Fennec Pharmaceuticals, Inc.
$24
TOLMAR Pharmaceuticals, Inc.
$23
Myriad Genetic Laboratories, Inc.
$23
Merck Sharp & Dohme LLC
$23
PharmaEssentia USA Corporation
$22
Pharmacyclics LLC, an AbbVie Company
$22
Karyopharm Therapeutics Inc.
$22
Dova Pharmaceuticals
$21
Taiho Oncology, Inc.
$19
Azurity Pharmaceuticals, Inc.
$19
Jazz Pharmaceuticals Inc.
$17
Stemline Therapeutics Inc.
$17
Bayer Healthcare Pharmaceuticals Inc.
$16
Kyowa Kirin, Inc.
$15
Helsinn Therapeutics (U.S.), Inc.
$15
Teva Pharmaceuticals USA, Inc.
$14
Janssen Pharmaceuticals, Inc
$12
Secura Bio, Inc.
$9
Clovis Oncology, Inc.
$6
Pfizer Inc.
$5
Top 3 companies account for 70.0% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · Abraxane · Alecensa · Avastin · BENDEKA · BESREMI · BOSULIF · BRAFTOVI · Balversa · Bavencio · CABLIVI · CALQUENCE · CINVANTI · COSELA · CYRAMZA · Cabometyx · DARZALEX · Doptelet · ELIGARD · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · ERLEADA · Enhertu · Erleada · Farydak · Folotyn · GAZYVA · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · Inrebic · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MVASI · MYLOTARG · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · OJJAARA · ONIVYDE · OPDIVO · OPDUALAG · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PRECISETUMOR · PROMACTA · PROSIGNA ASSAY · Pedmark · Phesgo · Pomalyst · Prolia · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · Tavalisse · Udenyca · VARUBI · VENCLEXTA · VERZENIO · VIVIMUSTA · VONJO · VOTRIENT · VYXEOS · XALKORI · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xtandi · ZEJULA · ZOLADEX · ZYTIGA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (49%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for internal medicine in FL.

Looking for a internal medicine in Miami Beach?
Compare internal medicines in the Miami Beach area by procedure volume, costs, and industry payment transparency.
Browse internal medicines nearby

Geographic Context

Internal Medicines within 10 mi
2,016
Per 100K population
75.1
County median income
$68,694
Nearest hospital
DOUGLAS GARDENS HOSPITAL
2.4 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Blanc is a internal medicine, and high industry engagement (speaking/promotional, top 1%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Blanc receive payments from pharmaceutical companies?
Yes. Dr. Blanc received a total of $117,207 from 67 companies across 456 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Blanc) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →